Dual-use APIs, which are being imported from unregistered companies,
are comparatively cheaper and of low-quality.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/central-drug-regulator-preparing-list-of-dual-use-apis-imported-from-unregistered-firms/articleshow/70825549.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment